One stock that may not have hit your radar yet in the cannabis craze that has coalesced over the past several weeks is Cannabis Strategic Ventures (OTCMKTS:NUGS). The company recently announced two different key acquisitions that suggest a growing momentum for this outfit as a venture player in the booming cannabis patch. That could make this stock pretty interesting as more eyeballs find it, especially given the tiny float in play for NUGS.
First, about 10 days ago, the company announced the signing of a definitive agreement to acquire the Fitamins CBD brand, a distributor of vitamin and hemp derived CBD formulations. Then, about a week ago, the company announced its acquisition of The Asher House Pet CBD brand from The Asher House LLC, effectively acquiring a line of U.S. hemp derived cannabidiol (CBD) supplements for pets.
Cannabis Strategic Ventures (OTCMKTS:NUGS) is a play on overall growth in the cannabis space. This is effectively a vehicle for strategic investments and acquisitions.
The company is based in Los Angeles and is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. The Company, recently completed a name and symbol change from Cascade Energy, Inc. Cannabis Strategic Ventures offers outsourced personnel solutions that are tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries, and other cannabis marketplace participants.
The company focuses on the fast-growing medical and legal recreational cannabis sectors.
The company will provide temporary, permanent, and long-term staffing solutions, employment and human resources consulting and Professional Employment Organization services to the legal Cannabis space.
According to company materials, “Cannabis Strategic Ventures is based in Los Angeles and is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. The Company recently completed a name and symbol change from Cascade Energy, Inc. Cannabis Strategic Ventures offers outsourced personnel solutions that are tailor made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries, and other cannabis marketplace participants. Cannabis Strategic Ventures is publicly traded on the U.S. Over the Counter Market with the stock symbol NUGS.”
Find out when $NUGS stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, NUGS is seeing a lot of activity of late as the company gets active in a big way for the first time as a player on the strategic investment side of the cannabis patch. Think of this as something like an attempt at being the Berkshire Hathaway of the cannabis space, grabbing high-growth bargains as acquisitions and strategic investments.
The two recent moves paint a picture of a current focus on CBD, where growth is already evident, and several plays have been taking off of late.
“Through the Asher House acquisition, Cannabis Strategic continues to expand its already diverse portfolio of Cannabis focus brands and service offerings. At Cannabis Strategic, we believe that investing in people is as important as investing in industry-leading products and technologies,” commented Mr. Simon Yu, CEO, of Cannabis Strategic. “Lee and Luke’s passion for pet adoption and pet wellness is one of the key ingredients to Asher House’s national recognition. We welcome Lee Asher and Luke Barton, the founders of Asher House, to the NUGS family.”
Recent action has seen 110% during the past month in terms of shareholder gains in the listing. Moreover, the listing has registered increased average transaction volume recently, with the past month seeing 700% above its longer-run average levels. This is particularly important with the stock trading on a float that is tiny at just 3.8M shares.
Earning a current market cap value of $1.4B, NUGS has a reserve ($165K) of cash on the books, which compares with about $213K in total current liabilities. One should also note that debt has been growing over recent quarters. NUGS is pulling in trailing 12-month revenues of $565K. In addition, the company is seeing recent top-line growth, with sequential quarterly revenues growing at 50.5%. This is an exciting story, and we look forward to a follow-up chapter as events transpire. Sign-up for continuing coverage on shares of $NUGS stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $NUGS, either long or short, and we have not been compensated for this article.